Speakers - Sachs Associates
Speakers - Sachs Associates
Speakers - Sachs Associates
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ADDRESS<br />
Otto-Hahn-Strasse 15<br />
D- 44227 Dortmund<br />
Germany<br />
TELEPHONE<br />
+49 231 9742 6300<br />
FAX<br />
+49 231 9742 6301<br />
EMAIL<br />
stefan.muellner@protagen.com<br />
YEAR FOUNDED<br />
1997<br />
Protagen AG<br />
www.protagen.com<br />
FINANCIAL SUMMARY<br />
Completed five rounds of financing totalling 15,3 Mio Euro (Years 2004-2010).<br />
COMPANY PROFILE<br />
The PROTAGEN GROUP is a leading provider of solutions for the pharmaceutical and biotech industries,<br />
supporting drug development towards personalized medicines and GMP compliant protein characterization<br />
services of outstanding quality.<br />
The PROTAGEN GROUP consists of PROTAGEN AG with a clear focus on diagnostics, and PROTAGEN Protein<br />
Services GmbH (PPS) providing GMP compliant protein analysis. PROTAGEN AG has developed the proprietary<br />
UNIarray® platform to support patient stratification and the development of Companion Diagnostics (CDx) using<br />
the diagnostic power of autoantibody signatures in blood. We combine our outstanding know-how in biostatistics<br />
and expertise in Protein arrays and Luminex technology for the development of novel diagnostic assays. Our<br />
R&D focus is on chronic diseases, e.g. neurodegenerative disorders, endometriosis, autoimmune diseases<br />
such as Rheumatoid Arthritis, Systemic Lupus Erythematosus and Multiple Sclerosis as well as selected cancer<br />
indications, e.g. Prostate-, Breast-, Ovarian-, Colon- and Pancreatic Cancer.<br />
PROTAGEN Protein Services GmbH (PPS) is a reliable partner for GMP compliant characterization of<br />
biotherapeutics (NBEs) and biosimilar comparability, including stability and release testing. PPS combines unique<br />
expertise in bioinformatics for protein mass spectrometry with a long track record in protein chemistry and<br />
protein analytics in order to provide the best quality available. In addition, we provide customer support for all<br />
relevant regulatory issues to match with current regulatory requirements (FDA, EMA, KFDA) for protein drugs.<br />
MANAGEMENT<br />
Dr Stefan Müllner, CEO<br />
Dr Peter Schulz-Knappe, CSO<br />
t back :: next u<br />
WELCOME PHARMA LICENSING GROUPS<br />
SPEAKERS<br />
PRESENTING COMPANIES SUPPORTING ORGANISATIONS<br />
ORGANISERS
Change language